News Financials About Visit Website Latest News Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website Sep. 11, 2023 9:30 AM ET FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH Aug. 21, 2023 9:00 AM ET CBIH Announces the Completion of the "Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project May. 1, 2023 9:00 AM ET More News Financials About Contact 214-733-0868 Visit Website CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings Apr. 24, 2023 9:00 AM ET Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company Apr. 17, 2023 9:00 AM ET CHNC Completes Review of Its First Three Fiscal Quarters Jul. 12, 2022 9:00 AM ET CHNC Announces Return of Half a Billion Shares Mar. 28, 2022 9:00 AM ET CHNC Announces Completion of Audited Financial Statements Mar. 23, 2022 12:37 PM ET CHNC - Alpha Research Institute Update Nov. 29, 2021 9:30 AM ET CHNC Continues to Position Itself as Colombia's Quintessential Medical Cannabis Educator Nov. 22, 2021 9:00 AM ET CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm Nov. 17, 2021 9:30 AM ET CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador Nov. 5, 2021 9:15 AM ET CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities Oct. 25, 2021 9:30 AM ET CHNC Announces a New Member of Its Board of Directors Oct. 20, 2021 9:30 AM ET CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content Oct. 18, 2021 9:00 AM ET CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics Oct. 1, 2021 9:00 AM ET CHNC's Shareholders Rewarded with Astonishing Investment Return of Over 2500% During this Last Year Sep. 22, 2021 9:15 AM ET CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors Sep. 10, 2021 9:30 AM ET CHNC Announces Name Change to Cannabis Bioscience International Holdings, Inc. Jun. 14, 2021 9:30 AM ET CHNC: Intensity, Determination and a Magical Unwavering Direction Transports CHNC to Become the Macondo of Medical Cannabis Research Mar. 17, 2021 9:30 AM ET CHNC Saga, Metamorphosis, and Transformation Feb. 5, 2021 9:30 AM ET CHNC Publishes Its Phytotherapy Project With Cannabinoids That Seeks to Attack the Effects of COVID-19 Nov. 18, 2020 8:15 AM ET CHNC Aims to Be the Global Leader in Cannabis Clinical Trials Through a Merger with Pharmacology University Oct. 28, 2020 8:00 AM ET
Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website Sep. 11, 2023 9:30 AM ET
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH Aug. 21, 2023 9:00 AM ET
CBIH Announces the Completion of the "Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project May. 1, 2023 9:00 AM ET
CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings Apr. 24, 2023 9:00 AM ET
Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company Apr. 17, 2023 9:00 AM ET
CHNC Continues to Position Itself as Colombia's Quintessential Medical Cannabis Educator Nov. 22, 2021 9:00 AM ET
CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm Nov. 17, 2021 9:30 AM ET
CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador Nov. 5, 2021 9:15 AM ET
CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities Oct. 25, 2021 9:30 AM ET
CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content Oct. 18, 2021 9:00 AM ET
CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics Oct. 1, 2021 9:00 AM ET
CHNC's Shareholders Rewarded with Astonishing Investment Return of Over 2500% During this Last Year Sep. 22, 2021 9:15 AM ET
CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors Sep. 10, 2021 9:30 AM ET
CHNC Announces Name Change to Cannabis Bioscience International Holdings, Inc. Jun. 14, 2021 9:30 AM ET
CHNC: Intensity, Determination and a Magical Unwavering Direction Transports CHNC to Become the Macondo of Medical Cannabis Research Mar. 17, 2021 9:30 AM ET
CHNC Publishes Its Phytotherapy Project With Cannabinoids That Seeks to Attack the Effects of COVID-19 Nov. 18, 2020 8:15 AM ET
CHNC Aims to Be the Global Leader in Cannabis Clinical Trials Through a Merger with Pharmacology University Oct. 28, 2020 8:00 AM ET
